RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BL PharmTech Stock

BL PharmTech Equity 2024

BL PharmTech Equity

31.42 B KRW

Ticker

065170.KQ

ISIN

KR7065170003

In 2024, BL PharmTech's equity was 31.42 B KRW, a -7.04% increase from the 33.8 B KRW equity in the previous year.

BL PharmTech Aktienanalyse

What does BL PharmTech do?

BL PharmTech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing BL PharmTech's Equity

BL PharmTech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding BL PharmTech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating BL PharmTech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

BL PharmTech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in BL PharmTech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about BL PharmTech stock

What is the equity of BL PharmTech this year?

BL PharmTech has equity of 31.42 B KRW this year.

What was the equity of BL PharmTech compared to the previous year?

The equity of BL PharmTech has increased/decreased by -7.04% decreased compared to the previous year.

What impact does a high equity have on investors of BL PharmTech?

A high equity is advantageous for investors of BL PharmTech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of BL PharmTech?

A low equity can be a risk for investors of BL PharmTech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of BL PharmTech affect the company?

An increase in equity of BL PharmTech can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of BL PharmTech affect the company?

A reduction in equity of BL PharmTech can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of BL PharmTech?

Some factors that can affect the equity of BL PharmTech include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of BL PharmTech so important for investors?

The equity of BL PharmTech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can BL PharmTech take to change the equity?

To change equity, BL PharmTech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does BL PharmTech pay?

Over the past 12 months, BL PharmTech paid a dividend of 94.86 KRW . This corresponds to a dividend yield of about 40.54 %. For the coming 12 months, BL PharmTech is expected to pay a dividend of 0 KRW.

What is the dividend yield of BL PharmTech?

The current dividend yield of BL PharmTech is 40.54 %.

When does BL PharmTech pay dividends?

BL PharmTech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BL PharmTech?

BL PharmTech paid dividends every year for the past 0 years.

What is the dividend of BL PharmTech?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is BL PharmTech located?

BL PharmTech is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von BL PharmTech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BL PharmTech from 4/14/2005 amounting to 120 KRW, you needed to have the stock in your portfolio before the ex-date on 12/29/2004.

When did BL PharmTech pay the last dividend?

The last dividend was paid out on 4/14/2005.

What was the dividend of BL PharmTech in the year 2023?

In the year 2023, BL PharmTech distributed 0 KRW as dividends.

In which currency does BL PharmTech pay out the dividend?

The dividends of BL PharmTech are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BL PharmTech

Our stock analysis for BL PharmTech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BL PharmTech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.